Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.37 CHF | -0.81% |
|
-1.23% | +8.65% |
06-12 | Swiss Market Index Close Little Changed; Novartis Shares Rise | MT |
06-12 | Novartis Reports 'Significant' Improvements in Study of Fabhalta to Treat PNH | MT |
Main competitors
P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
17.22x | 5.11x | 0.99x | 4.61x | 11.13x | 12.02x | 3.3% | 235B | ||
38.64x | 28.06x | 0.48x | 12.76x | 29.05x | 31.38x | 0.73% | 736B | ||
15.05x | 5.12x | 0.19x | 4.19x | 11.54x | 12.84x | 3.33% | 378B | ||
28.57x | 46.84x | 0.16x | 6.55x | 13.63x | 14.02x | 3.42% | 338B | ||
14.76x | 5.55x | 0.19x | 3.6x | 8.95x | 10.26x | 3.66% | 266B | ||
23.39x | 5.17x | 0.56x | 4.35x | 12.82x | 13.59x | 2.15% | 232B | ||
10.47x | 3.71x | 0.66x | 3.39x | 7.31x | 8.13x | 3.94% | 205B | ||
21.88x | 17.57x | 0.28x | 5.78x | 11.21x | 13.11x | 3.25% | 159B | ||
11.53x | 1.54x | 0.23x | 2.85x | 7.04x | 8.16x | 6.96% | 140B | ||
18.26x | 6.06x | 0.01x | 5.17x | 9.43x | 11.39x | 2.96% | 137B | ||
11.6x | 1.33x | 0.18x | 2.52x | 8.14x | 9.05x | 4.77% | 122B | ||
30.24x | 5.87x | -0.04x | 9.05x | 19x | 19.97x | -.--% | 117B | ||
11.09x | 4.69x | -0.05x | 2.89x | 7.58x | 7.9x | 4.98% | 101B | ||
28.15x | 6.18x | 2.24x | 9.41x | 18.61x | 19.35x | 3.21% | 85.23B | ||
10.51x | 4.16x | 0.08x | 2.31x | 6.83x | 7.8x | 4.3% | 83.24B | ||
48.39x | 6.52x | 4.26x | 10.6x | 39.78x | 42.63x | 0.45% | 49.75B | ||
22.32x | 2.14x | 1.72x | 3.83x | 15.33x | 17.26x | 1.77% | 48.43B | ||
51.6x | 0.96x | -6.09x | 2.4x | 9.05x | 30.65x | 4.51% | 47.17B | ||
27.34x | 3.9x | 1.19x | 3.17x | 17.08x | 20.34x | 1.71% | 45.59B | ||
Average | 23.21x | 8.45x | 0.38x | 5.23x | 13.87x | 16.31x | 3.13% | 185.46B | |
Weighted average by Cap. | 23.66x | 14.10x | 0.39x | 6.41x | 15.30x | 16.94x | 2.84% |
- Stock Market
- Equities
- NOVN Stock
- Sector Novartis AG
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition